Crossmark

Development of parasitic disease biobank and new antileishmanial agents

Crossref DOI link: https://doi.org/10.1007/s12639-025-01898-w

Published Online: 2026-01-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kumar, Awanish https://orcid.org/0000-0001-8735-479X
License Information

Text and Data Mining valid from 2026-01-10

Version of Record valid from 2026-01-10
More Information

Article History

Received: 13 December 2024

Accepted: 20 December 2025

First Online: 10 January 2026

Declarations

:

: None.

: This article does not contain any studies involving human participants.